Abstract
The present paper describes protective effects of supplemental selenium in mice infected with influenza virus. The effects of supplemental selenium on serum selenium levels, mortality, lung virus titers, and cytokine titers were investigated in mice inoculated intranasally with suspensions of influenza virus. Whereas the mortality of the virus-infected Se-deficient mice was 75%, along with a marked reduction in body weight, lower levels of TNF-α and IFN-γ and lower serum selenium concentrations, the mortality of mice maintained on feed containing 0.5 mg Se/kg in the form of sodium selenite was 25%.There were no significantly differences, however, in viral titer between the Se-adequate and the selenium-supplemented groups. The data indicate that selenium supplementation may provide a feasible approach to improving the immune response to viral infections, such as lethal influenza infection.
Similar content being viewed by others
Introduction
Several studies have shown that selenium deficiency enhances the susceptibility to infections including respiratory virus infections [1–3]. This increase in susceptibility is believed to result from an impaired host immune response due to a deficient diet. Furthermore, selenium deficiencies of the host can also affect viral pathogens themselves resulting in viral species that are more virulent than the parent species [4, 5]. Barnard DL reported that the prophylactic use of ZnAL42 is effective against avian influenza H5N1 or H1N1 virus infection in mice [6].
The pandemic 2009 (H1N1) is spreading to numerous countries and causing many human deaths. By August 13, 2009 the World Health Organization (WHO) has announced as many as 182,166 confirmed cases and a death toll of 1,799 with a mortality rate of 0.99%. In Mainland China alone, the Centers for Disease Control reported 2,861 cases by August 19, 2009. The influenza virus shows high genetic variability, resulting in the rapid emergence of pathogens resistant to antiviral drugs pathogens. It is suggested that supplementation with selenium might provide prophylactic protection against influenza infection. Therefore, we developed in vivo models of Se-deficient, Se-adequate, and Selenium-supplemented mice and determined the effects of supplementation with selenium on serum selenium levels, mortality, lung virus titers, and influenza-induced cytokine production.
Materials and Methods
Animals
Kunming strain mice weighing 20–22 g were maintained at room temperature under alternating natural light/dark photoperiods, and had access to standard laboratory food and fresh water ad libitum. This study was performed in accordance with the Guide for the Care and Use of Laboratory Animals. Care was taken to minimize discomfort, distress, and pain to the animals.
All the chows had the recommended nutrients differing only in the selenium levels (Table 1).
The mice (n = 120) were randomly assigned to continue receiving Se-adequate chow (0.2 mg Se/kg in the form of sodium selenite pentahydrate), Se-deficient chow (0 mg Se/kg in the form of sodium selenite pentahydrate), and Selenium-supplemented chow (0.3, 0.4, and 0.5 mg Se/kg in the form of sodium selenite pentahydrate) for 8 weeks, respectively.
Influenza Virus Infection
Influenza A/NWS/33 (H1N1) was obtained from the Chinese Academy of Sciences. Virus pools were prepared by infecting confluent monolayers of Madin-Darby canine kidney epithelial cells (MDCK) cells, incubating them at 37°C in 5% CO2, and harvesting the cells at 3-5 days when viral cytopathic effect was 90-100%. The medium for the virus-infected cells contained MEM, 0.18% NaHCO3, 20 µg of trypsin per mL, 2 µg of EDTA per mL, and 50 µg of gentamicin per mL. All virus stocks were placed in ampoules and frozen at −80°C before use.
Mice (5 weeks old) were inoculated intranasally with 50 µL of viral suspension (2 × 105 PFU/mouse). A number of mice (n = 12) were observed for 21 days to monitor body weight change and mortality. In other groups of mice, blood, and the lung were individually collected at 3 and 5 days after virus inoculation \( \left( {n = {4} - {6}\;{\hbox{each}}} \right) \).
Determination of Lung Virus Titers
Each mouse lung was homogenized and varying dilutions were assayed in triplicate for infectious virus in MDCK cells as described previously [7–9]. Briefly, after incubation at 37°C for 24 h, 0.002% L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin (Sigma) was added, followed by a 72-h incubation. Chicken red blood cells were prepared at 1% in phosphate-buffered solution (PBS) and added to cultures. Virus titers were then calculated based on the hemagglutination pattern and reported as the 50% tissue culture infectious dose (TCID50).
Determination of Cytokines
Tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) in blood were assayed by the ELISA technique. Each sample was diluted tenfold with PBS, and then 50 μL of the dilution were incubated in a 96-well formatted flexible plate at 37°C for 1 h. After three washings with PBS, uncoupled binding sites in the wells were blocked with 10% skim milk in PBS. After three washings with PBS containing 0.05% Tween 20, the plate was incubated at 37°C for 1 h in the presence of rabbit antimouse/rat TNF-α or rabbit antimouse IFN-γ antibodies (Shanghai yueyan Biological Technology Co., Ltd, China). The plate was then developed using peroxidase-labeled goat antirabbit IgG (Asbio Technology, Inc., China) and peroxidase substrate [10].
Determination of Serum Selenium Levels
Plasma samples were obtained after centrifugation of blood in a microhematocrit centrifuge and were stored at −22°C until analysis. The plasma levels of selenium were measured by means of an atomic absorption spectrometer AAS-3200 (Shanghai, China) with a limit of sensitivity of 64 nM (5 ng/mL) according to the method introduced by Andrea P [4]. Undetectable concentrations were assigned a value of 5 ng/mL [5].
Statistical Analyses
Results are expressed as means ± standard error of the mean. Increases in survivor numbers were evaluated using x 2 analysis with Yates’ correction. Differences in others were compared with control values using the t test. The significant level of 5% (p < 0.05) was used as the minimum acceptable probability for the difference between the means.
Results and Discussion
The ongoing spread of the human swine-origin H1N1 influenza virus meets the WHO criteria for a pandemic [11]. Although vaccines are an effective method of preventing infection, their efficacy in protecting against a possible new pandemic influenza virus strain depends very much on the quality of vaccine [12]. It is suggested that nutritional supplementation in vitamins or trace elements might provide prophylactic protection against influenza infection including respiratory virus infections [13–16]. Selenium is an essential micronutrient in the diet of humans and other mammals. This trace element seems to be important for mounting immune responses to viral infections, whereas deficiencies in selenium have been demonstrated to result in more severe viral infections, including HIV and Coxsackie virus [17–21].
Our data in this study indicate that selenium supplementation would protect mice from lethal influenza infection. Se-supplemented mice demonstrated a dose-dependent increase in survival (Table 2) and a reduction in loss of body weight, an important indicator of the severity of infection (Fig. 1). Se-deficient mice showed high mortality (75%) with a marked reduction in body weight. In Se-supplemented (0.4 and 0.5 mg/kg) mice, although the loss in body weight was also found, the mortality (25%) was significantly lower than that of the Se-deficient group.
To examine whether or not selenium supplementation could suppress the virus loads in mice, virus titers in the lung were determined at 3 and 5 days of virus inoculation. The lung influenza viral titer was higher in Se-deficient animals. However, there were no differences in viral titer between the Se-adequate and the Se-supplemented groups. These results suggested that selenium did not show direct interaction with virus particles. Therefore, the protective effect of selenium observed in the mouse model was suggested to be involved in host mediated mechanism(s) such as the stimulating effect of host immune function. Thus, in the next experiments, the effects of selenium supplementation were determined on the levels of TNF-α and IFN-γ (Fig. 2).
TNF-α and IFN-γ are well known to possess an antiviral effect against influenza virus infection. In particular, TNF-α has been reported to exert an anti-influenza virus effect [22]. Thus, the effect of selenium supplementation on the stimulation of TNF-α and IFN-γ production could contribute to their anti-influenza virus activity in animals. Indeed, the levels of cytokines including TNF-α and IFN-γ were increased in Se-supplemented mice (Fig. 3). At 3 days post-infection, there was no difference in cytokine levels between the Se-deficient and the Se-supplemented groups (Fig. 3a, b). At 5 days post-infection, however, both TNF-α and IFN-γ were increased in the blood samples of Se-supplemented mice, whereas less increase was observed in Se-deficient and Se-adequate mice (Fig. 3c, d). Therefore, the protective effect of selenium supplementation on lethal influenza virus infection might be due at least in part to the enhancement of TNF-α and IFN-γ production.
Several studies have shown that low serum selenium levels were associated with low percentage of NK cells [23]. In addition, deprivation of serum selenium in HIV infection is associated with increased levels of markers of disease progression and inflammatory response [24]. Table 3 shows the effects of selenium supplementation on serum selenium concentrations. Se-deficient mice had mean values for serum selenium (0.062 μg/mL). These values were significantly lower than those of Se-adequate and Se-supplemented mice (0.148 μg/mL, 0.159 μg/mL, 0.170 μg/mL, and 0.178 μg/mL, respectively). It is speculated that the effect of selenium supplementation on serum selenium concentrations may modulate the effect of viral or other infections and contribute to its anti-influenza virus activity in animals.
Conclusions
The results presented here further our understanding of the importance of selenium supplementation in the response to viral disease. Se-deficient mice had an altered immune response to influenza virus infection. Lower serum selenium in Se-deficient mice contributed to less production of TNF-α and IFN-γ and to lower survival rates. Our data in this study indicate that selenium supplementation may constitute a feasible approach to improving the immune response to viral infections, such as lethal influenza infection.
References
Ferencik M, Ebringer L (2003) Modulatory effects of selenium and zinc on the immune system. Folia Microbiol (Praha) 48:417–426
Nelson HK, Shi Q, Van Dael P et al (2001) Host nutritional selenium status as a driving force for influenza virus mutations. FASEB J 15:1846–1848
Korunova V, Skodova Z, Dedina J et al (1993) Serum selenium in adult Czechoslovak (central Bohemia) population. Biol Trace Elem Res 37:91–99
Andrea P, de Souza G, de Oliveira M, Neve J et al (2002) Trypanosoma cruzi: host selenium deficiency leads to higher mortality but similar parasitemia in mice. Exp Parasitol 101:193–199
Moreno-Reyes R, Egrise D, Neve J et al (2001) Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J Bone Miner Res 16:1556–1563
Barnard DL, Wong MH, Bailey K et al (2007) Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice. Antivir Chem Chemother 18(3):125–132
Sidwell RW, Huffman JH, Call EW et al (1986) Effect of selenazofurin on influenza A and B virus infections of mice. Antivir Res 6:343–353
Po JL, Gardner EM, Anaraki F et al (2002) Ageassociated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech Ageing Dev 123:1167–1181
Nogusa S, Ritz BW, Kassim SH et al (2008) Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 129:223–230
Peticevich V, Lebrun I (2005) Immunomodulatory effects of the Tityus serrulatus venom on murine macrophage functions in vitro. Mediat Inflamm 24:39–49
Cohen J, Enserink M (2009) Swine flu. After delays, WHO agrees: the 2009 pandemic has begun. Science 324:1496–1497
Ohta Y, Lee JB, Hayashi K, Fujita A et al (2007) In vivo anti-influenza virus activity of an immunomodulatory acidic polysaccharide isolated from Cordyceps militaris grown on germinated soybeans. J Agric Food Chem 55(25):10194–10199
Bhaskaram P (2001) Immunobiology of mild micronutrient deficiencies. Br J Nutr 85(Suppl 2):75–80
Cunningham-Rundles S, McNeeley DF, Moon A (2005) Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 115:1119–1128
Beck MA, Handy J, Levander OA (2004) Host nutritional status: the neglected virulence factor. Trends Microbiol 12:417–423
Stephensen CB, Blount SR, Schoeb TR, Park JY (1993) Vitamin A deficiency impairs some aspects of the host response to influenza A virus infection in BALB/c mice. J Nutr 123:823–833
Baum MK, Miguez-Burbano MJ, Campa A, Shor-Posner G (2000) Selenium and interleukins in persons infected with human immunodeficiency virus type 1. J Infect Dis 182(Suppl 1):69–73
Gladyshev VN, Stadtman TC, Hatfield DL, Jeang K-T (1999) Levels of majorselenoproteins in T cells decrease during HIV infection and low molecularmass selenium compounds increase. Proc Natl Acad Sci USA 96:835–839
Beck M, Shi Q, Morris V, Levander O (1995) Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1:433–436
Beck M, Kolbeck P, Rohr L, Shi Q, Morris V, Levander O (1994) Benign human enterovirus becomes virulent in selenium-deficient mice. J Med Virol 43:166–170
Beck MA, Williams-Toone D, Levander OA (2003) Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency. Free Radic Biol Med 34:1263–1270
Seo SH, Webster RG (2002) Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol 76:1071–1076
Ravaglia G, Forti P, Maioli F et al (2000) Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged >/=90 y. Am J Clin Nutr 71:590–588
Look MP, Rockstroh JK, Rao GS et al (1997) Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 56:31–41
Acknowledgment
This project was supported by a project of the HeiLongJiang Provincial Health Department (NO.2009-201).
Author information
Authors and Affiliations
Corresponding author
Additional information
Lei Yu and Lei Sun are equal contribution to the paper.
Rights and permissions
About this article
Cite this article
Yu, L., Sun, L., Nan, Y. et al. Protection from H1N1 Influenza Virus Infections in Mice by Supplementation with Selenium: A Comparison with Selenium-Deficient Mice. Biol Trace Elem Res 141, 254–261 (2011). https://doi.org/10.1007/s12011-010-8726-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-010-8726-x